These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22286599)

  • 41. Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance.
    Ovrum E; Am Holen E; Tangen G; Ringdal MA
    Ann Thorac Surg; 1996 Oct; 62(4):1128-33. PubMed ID: 8823101
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of allogenic red cell transfusion and coated bypass circuit on the inflammatory response during cardiopulmonary bypass: a randomized study.
    Senay S; Toraman F; Gunaydin S; Kilercik M; Karabulut H; Alhan C
    Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):93-9. PubMed ID: 18801802
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aspirin does not increase allogeneic blood transfusion in reoperative coronary artery surgery.
    Tuman KJ; McCarthy RJ; O'Connor CJ; McCarthy WE; Ivankovich AD
    Anesth Analg; 1996 Dec; 83(6):1178-84. PubMed ID: 8942582
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical evaluation of heparin-coated circuits for routine coronary artery bypass grafting surgery: a prospective randomized study.
    Collart F; Caus T; Pomane C; Pellissier V; Chi Y; Montiès JR; Mesana T
    Artif Organs; 2000 Aug; 24(8):611-3. PubMed ID: 10971246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coagulation, fibrinolysis, and cell activation in patients and in shed mediastinal blood during coronary artery bypass grafting with a new heparin-coated surface.
    Baufreton C; de Brux JL
    J Thorac Cardiovasc Surg; 2003 Dec; 126(6):2116. PubMed ID: 14688752
    [No Abstract]   [Full Text] [Related]  

  • 46. Use of modified ultrafiltration in adults undergoing coronary artery bypass grafting is associated with inflammatory modulation and less postoperative blood loss: a randomized and controlled study.
    Torina AG; Silveira-Filho LM; Vilarinho KA; Eghtesady P; Oliveira PP; Sposito AC; Petrucci O
    J Thorac Cardiovasc Surg; 2012 Sep; 144(3):663-70. PubMed ID: 22578899
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Active or passive bio-coating: does it matters in extracorporeal circulation?
    Jacobs S; De Somer F; Vandenplas G; Van Belleghem Y; Taeymans Y; Van Nooten G
    Perfusion; 2011 Nov; 26(6):496-502. PubMed ID: 21719530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and biomaterial evaluation of a new condensed dual-function extracorporeal circuit in reoperation for coronary artery bypass surgery.
    Gunaydin S; McCusker K; Vijay V
    Int J Artif Organs; 2009 Nov; 32(11):802-10. PubMed ID: 20020412
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiopulmonary bypass copolymer surface modification reduces neither blood loss nor transfusions in coronary artery surgery.
    Südkamp M; Mehlhorn U; Reza Raji M; Hekmat K; Easo J; Geissler HJ; Sindhu D; de Vivie R
    Thorac Cardiovasc Surg; 2002 Feb; 50(1):5-10. PubMed ID: 11847596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thromboresistant surfaces with low-dose anticoagulation alleviate clopidogrel-related complications in patients undergoing coronary artery bypass grafting.
    Hussaini BE; Thatte HS; Rhodes BA; Treanor PR; Birjiniuk V
    J Thorac Cardiovasc Surg; 2011 Mar; 141(3):782-8. PubMed ID: 21146837
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations.
    Ovrum E; Tangen G; Oystese R; Ringdal MA; Istad R
    J Thorac Cardiovasc Surg; 2001 Feb; 121(2):324-30. PubMed ID: 11174738
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Beating-heart coronary artery bypass grafting with miniaturized cardiopulmonary bypass results in a more complete revascularization when compared to off-pump grafting.
    Reber D; Brouwer R; Buchwald D; Fritz M; Germing A; Lindstaedt M; Klak K; Laczkovics A
    Artif Organs; 2010 Mar; 34(3):179-84. PubMed ID: 20447041
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduced systemic heparin dose with phosphorylcholine coated closed circuit in coronary operations.
    Ranucci M; Isgrò G; Soro G; Canziani A; Menicanti L; Frigiola A
    Int J Artif Organs; 2004 Apr; 27(4):311-9. PubMed ID: 15163065
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heparin-coated circuits (Duraflo II) with reduced versus full anticoagulation during coronary artery bypass surgery.
    Ovrum E; Tangen G; Oystese R; Ringdal MA; Istad R
    J Card Surg; 2003; 18(2):140-6. PubMed ID: 12757341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heparin-bonded cardiopulmonary bypass circuits reduce the rate of red blood cell transfusion during elective coronary artery bypass surgery.
    Kreisler KR; Vance RA; Cruzzavala J; Mahnken JD
    J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):608-11. PubMed ID: 16202894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Miniaturized versus conventional cardiopulmonary bypass and acute kidney injury after cardiac surgery.
    Chew ST; Ng RR; Liu W; Goh SG; Caleb MG; Ti LK
    Perfusion; 2016 Jan; 31(1):60-7. PubMed ID: 25910838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of tranexamic acid on short-term and long-term outcomes of on-pump coronary artery bypass grafting: Randomized trial and 7-year follow-up.
    Zhang Y; Gao X; Yuan S; Guo J; Lv H; Zhou Y; Wang Y; Ji H; Wang G; Li L; Shi J
    Cardiovasc Ther; 2018 Dec; 36(6):e12472. PubMed ID: 30372588
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is there really a benefit of using minimized cardiopulmonary bypass in CABG? A retrospective propensity score-matched study with 5000 cases.
    Provaznik Z; Zeman F; Camboni D; Creutzenberg M; Unterbuchner C; Philipp A; Foltan M; Schmid C; Floerchinger B
    Heart Vessels; 2020 Jan; 35(1):14-21. PubMed ID: 31236675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heparin-coated circuits and reduced systemic anticoagulation applied to 2500 consecutive first-time coronary artery bypass grafting procedures.
    Øvrum E; Tangen G; Tølløfsrud S; Ringdal MA
    Ann Thorac Surg; 2003 Oct; 76(4):1144-8; discussion 1148. PubMed ID: 14530001
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of one-stop hybrid coronary revascularization on postoperative renal function and bleeding: a comparison study with off-pump coronary artery bypass grafting surgery.
    Zhou S; Fang Z; Xiong H; Hu S; Xu B; Chen L; Wang W
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1511-1516.e1. PubMed ID: 23879931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.